Case Study: Global Oncology

The sponsor of a Phase 3 oncology study faced several challenges in recruiting patients for their study on the effectiveness of their drug in preventing cervical cancer recurrence in high-risk women. The financial burden and the hesitancy of oncology patients to participate in a preventative protocol were major obstacles. To address these issues, the sponsor implemented various strategies to increase patient recruitment and retention.

However, the sponsor found that it still needed support. After being brought on to help, one of the key services Scout provided was the drafting of appropriate language for regulatory approval, ensuring that all necessary ethical and legal requirements were met. Scout also guided the submission process, assisting the sponsor in navigating the complex regulatory landscape. In addition, Scout created patient and site documentation, ensuring that all necessary paperwork and forms were accurately prepared and readily available. This streamlined the enrollment process and made it easier for patients to participate.

Delve into all the details of this case study to uncover how Scout was instrumental in supporting the Phase 3 oncology study and ensuring the successful recruitment and retention of high-risk women for the evaluation of the drug's effectiveness in preventing cervical cancer recurrence.